Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

Related Articles by Review for PubMed (Select 21414516)

1.

Predicting the risk of pelvic node involvement in men with prostate cancer in the contemporary era: change you can believe?: in regard to Yu, et al. (Int J Radiat Oncol Biol Phys in press).

Hayes M, Roach M 3rd.

Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1598; author reply 1598-9. doi: 10.1016/j.ijrobp.2010.11.008. No abstract available.

PMID:
21414516
2.

Lymph node assessment and lymphadenectomy in prostate cancer.

Ordon M, Nam RK.

J Surg Oncol. 2009 Mar 15;99(4):215-24. doi: 10.1002/jso.21225. Review.

PMID:
19170044
3.
4.

Pelvic lymph node dissection in prostate cancer.

Briganti A, Blute ML, Eastham JH, Graefen M, Heidenreich A, Karnes JR, Montorsi F, Studer UE.

Eur Urol. 2009 Jun;55(6):1251-65. doi: 10.1016/j.eururo.2009.03.012. Epub 2009 Mar 10. Review.

PMID:
19297079
5.

Pelvic lymph node irradiation for prostate cancer: who, why, and when?

Wang D, Lawton C.

Semin Radiat Oncol. 2008 Jan;18(1):35-40. Review.

PMID:
18082586
6.

Indications for pelvic lymphadenectomy in prostate cancer.

Link RE, Morton RA.

Urol Clin North Am. 2001 Aug;28(3):491-8. Review.

PMID:
11590808
7.

Prostate cancer: pelvic nodes revisited--sites, incidence and prospects for treatment with radiotherapy.

Neal AJ, Dearnaley DP.

Clin Oncol (R Coll Radiol). 1993;5(5):309-12. Review. No abstract available.

PMID:
8305340
8.

Lymph node staging in clinically localized prostate cancer.

Wawroschek F, Hamm M, Weckermann D, Vogt H, Harzmann R.

Urol Int. 2003;71(2):129-35. Review. No abstract available.

PMID:
12890947
9.

Endocavitary (laparoscopic) pelvic lymphadenectomy with specific indications in urologic surgery.

Boullier JA, Hagood PG, Parra RO.

Urology. 1993 Jan;41(1 Suppl):19-25. Review.

PMID:
7678361
10.

[Is pelvic irradiation still justified in the treatment of prostate cancer by exclusive radiotherapy?].

Chapet O, Quero L, Azria D, Bossi A, Hennequin C, Paparel P.

Cancer Radiother. 2009 Sep;13(5):416-22. doi: 10.1016/j.canrad.2008.11.006. Epub 2009 Jan 23. Review. French.

PMID:
19167919
11.

Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up.

Carroll P, Coley C, McLeod D, Schellhammer P, Sweat G, Wasson J, Zietman A, Thompson I.

Urology. 2001 Feb;57(2):225-9. Review. No abstract available.

PMID:
11182325
12.

The case against extended lymph-node dissection for prostate cancer.

Huland H.

Nat Clin Pract Urol. 2006 Sep;3(9):456-7. Review. No abstract available.

PMID:
16964181
13.

Review of staging modalities in clinically localized prostate cancer.

Perrotti M, Pantuck A, Rabbani F, Israeli RS, Weiss RE.

Urology. 1999 Aug;54(2):208-14. Review. No abstract available.

PMID:
10443712
14.

An extended pelvic lymph-node dissection should be performed in most patients if radical prostatectomy is truly indicated.

Burkhard FC, Schumacher MC, Studer UE.

Nat Clin Pract Urol. 2006 Sep;3(9):454-5. Review. No abstract available.

PMID:
16964180
15.

[Significance of micrometastases in pelvic lymph nodes from patients with localized prostate cancer].

Miyake H, Fujisawa M.

Nihon Rinsho. 2011 Jun;69 Suppl 5:651-5. Review. Japanese. No abstract available.

PMID:
22208060
16.

The role of elective pelvic radiotherapy in clinically node-negative prostate cancer: a systematic review.

Dirix P, Joniau S, Van den Bergh L, Isebaert S, Oyen R, Deroose CM, Lerut E, Haustermans K.

Radiother Oncol. 2014 Jan;110(1):45-54. doi: 10.1016/j.radonc.2013.06.046. Epub 2013 Aug 27. Review.

PMID:
23993400
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk